Since type III collagen expression is a dominant feature of tendinopathy, as compared with type I collagen, we next considered whether IL-17A might alter differential collagen synthesis by tenocytes utilising a previously characterized in vitro system31. The gene discussed is IL17A; the disease is disease of the tendon.